Maternal Exposure of Phthalates in Low-Birth-Weight Newborns: A Case-Control Study in Shanghai, China.

Yunhui Zhang,Ling Lin,Yang Cao,Bingheng Chen,Ren‐Shan Ge
DOI: https://doi.org/10.1093/biolreprod/78.s1.198b
2008-01-01
Biology of Reproduction
Abstract:At present, more than 30 million low-birth-weight (LBW) infants are born annually (23.8% of all births) worldwide. Those LBW infants are significantly more susceptible to other infections and have a higher risk of dying during infancy. It is generally agreed that maternal nutrition and social-economic status are the main risk factors underlying the pathology of LBW. Recent animal data show that LBW is the most sensitive endpoint of developmental toxicity some environmental endocrine disruptors (EEDs), such as di-n-butyl phthalate (DBP). Therefore, the present study was designed to investigate the relationship between phthalates exposure and LBW in humans, using a case-controlled panel study of a population in Shanghai, China. From Jan. 2006 through Jan. 2007, 201 consecutive newborns (including 88 term LBW newborns as cases, and 113 term infants as controls), delivered at Shanghai Healthcare Center for Maternal and Children, were investigated by questionnaires. All participants signed the written informed consents for attending this case-control study. We analyzed maternal and umbilical cord blood for four kinds of phthalates (di-2-ethylhexyl phthalate, DEHP; mono-2-ethylhexyl phthalate, MEHP; di-ethyl phthalate, DEP; di-n-butyl phthalate, DBP) by the method of liquid chromatography-mass spectrometry (LC-MS). The binomial Logistic regression, Spearman correlation and linear regression methods were used to analyze the potential risk factors of LBW and their relationship with phthalates exposure. Among seventy factors we investigated in questionnaires, multivariate models showed that there were only three risk factors (presence of cord loops, dysmenorrheal history, and source of drink water) which have significantly related with LBW (P£¼0.05). Furthermore, maternal diseases before pregnancy and during gestation were also found to have negative association with birth length of newborns. Above 70% of serum samples had quantifiable levels of phthalates in maternal-infant pairs of case and control group. The levels of these chemicals in maternal blood samples were higher than those in cord blood of their newborns. Statistically, there are significantly higher levels of phthalates in cord blood serum in LBW infants than those of the controls (2.0mg/L vs. 1.9mg/L for DEP, 2.55mg/L vs. 2.02mg/L for DBP, 0,74mg/L vs. 0.63mg/L for DEHP, 2.50mg/L vs. 1.27mg/L for MEHP). Moreover, there was a significant correlation between the birth weight and the levels of DBP and MEHP (P<0.001). The present results showed that phthalates and their metabolites could pass the blood-placenta barriers in humans. Phthalates exposure, especially DBP and DEHP in drink water, might be potential environmental risk factors of low birth weight in newborns. This research was supported by Natural Science Foundation of China No.30500397 (Y.H.Z.) and in part by the Bixby Foundation (Y.H.Z.).
What problem does this paper attempt to address?